Talk:Migalastat

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Migalastat.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

A fact from Migalastat appeared on Wikipedia's Main Page in the Did you know column on 11 June 2016 (check views). The text of the entry was as follows:

Did you know... that the pharmaceutical drug migalastat fights Fabry disease by correcting the way a mutated enzyme is folded?

A record of the entry may be seen at Wikipedia:Recent additions/2016/June. The nomination discussion and review may be seen at Template:Did you know nominations/Migalastat.

Wikipedia

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Approval Fast-Track Controversy

Since this drug is popping up in news media as having a controversial approval process that ignored FDA guidance at the behest of Donald Trump, it would be a disservice not to include a section on that here.

Washington Post article about price hike and approval

— Preceding unsigned comment added by 55.23.80.38 (talk) 17:07, 19 April 2018 (UTC)[reply]

That WaPo article is about ibrutinib and doesn't mention this drug or Trump. This drug is not approved in the US yet. Jytdog (talk) 17:20, 19 April 2018 (UTC)[reply]